Assessment of Extracellular Fluid Volume and Fluid Status in Hemodialysis Patients: Current Status and Technical Advances
被引:46
|
作者:
Dou, Yanna
论文数: 0引用数: 0
h-index: 0
机构:
Renal Res Inst, New York, NY 10128 USA
Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
Peking Univ, Div Renal, Hosp 1, Beijing 100871, Peoples R ChinaRenal Res Inst, New York, NY 10128 USA
Dou, Yanna
[1
,2
,3
]
Zhu, Fansan
论文数: 0引用数: 0
h-index: 0
机构:
Renal Res Inst, New York, NY 10128 USA
Beth Israel Deaconess Med Ctr, New York, NY 10003 USARenal Res Inst, New York, NY 10128 USA
Zhu, Fansan
[1
,2
]
Kotanko, Peter
论文数: 0引用数: 0
h-index: 0
机构:
Renal Res Inst, New York, NY 10128 USA
Beth Israel Deaconess Med Ctr, New York, NY 10003 USARenal Res Inst, New York, NY 10128 USA
Kotanko, Peter
[1
,2
]
机构:
[1] Renal Res Inst, New York, NY 10128 USA
[2] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[3] Peking Univ, Div Renal, Hosp 1, Beijing 100871, Peoples R China
The assessment of extracellular fluid volume (ECV) and fluid status is both important and challenging in hemodialysis patients. Extracellular fluid is distributed in two major sub-compartments: interstitial fluid and plasma. A variety of methods are used to assess the ECV, with tracer dilution techniques considered gold standard. However, ECV defined as the distribution space of bromide, sodium, chloride, and ferrocyanide appears to be larger than the distribution volume of inulin and sucrose, suggesting a partial distribution into the intracellular volume. Relative blood volume monitoring, measurement of inferior vena cava diameter by ultrasound and biochemical markers are indirect methods, which do not reflect the ECV and fluid status accurately. Bioimpedance spectroscopy (BIS) techniques enable assessment of ECV and intracellular volume. Currently, BIS appears to be the most practical method for assessing ECV volume and fluid status in dialysis patients.